NYC Dept. Health / Mental Hygiene Screening for Depression
NYC Dept. Health / Mental Hygiene Screening for Depression
– designed to ensure the entire US population ranks as depressed
Similar Posts
I hope you all believe in Santa Claus
I hope you all believe in Santa Claus Wed, 15 Dec 2004 According to “a new study” PhaRma is wasting money on detailing… According to Washington & Columbia University – the docs aren’t paying attention – So how come the industry has the highest profit return – because they throw…
Dr. Wolpe’s Accusations and Dr. Healy’s Response
Dr. Wolpe’s Accusations and Dr. Healy’s Response —–Original Message—– From: Paul Root Wolpe Sent: Tuesday, October 28, 2003 4:30 PM To: VERACARE Subject: Re: Ethics of U Penn surgical “drug implant” experiment Vera, We will have to agree to disagree, so this will be my last email on this. A…
Smallpox Researchers Seek Help from Millions of Computer Users
Smallpox Researchers Seek Help from Millions of Computer Users Wed, 5 Feb 2003 The Defense Department and a group of academic institutions is announcing “a networked computer project intended to accelerate the search for a cure for smallpox.” The public is asked to share unused personal computer space with the…
Time to put drug giants on trial – Scotsman (UK)
Time to put drug giants on trial – Scotsman (UK) Fri, 20 Jun 2003 The UK media-including BBC, the Guardian, the Scotsman, the London Times, and others–have been informing the British public about the hidden health hazards underlying the industry-controlled drug approval and drug marketing process. Current practices have led…
Article
June 18, 2003. GlaxoSmithKline, manufacturer of Paroxetine (Seroxat, Paxil) issued a letter addressed to British Healthcare Professionals, disclosing that the drug was found be linked to serious undesirable effects in depressed children and adolescents under age 18. Below is an excerpt followed by the original letters: UNDESIRABLE EFFECTS Adverse events…
Complaint to FDA: Pfizer Failed to Disclose Zoloft Suicide Risk in NYT Adverstisement
Complaint to FDA: Pfizer Failed to Disclose Zoloft Suicide Risk in NYT Adverstisement Mon, 1 Nov 2004 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Tel. 212-595-8974 142 West End Ave. Suite 28P Fax: 212-595-9086 New York, NY 10023 www.ahrp.org November 1, 2004 Thomas W. Abrams Director Office…